SCHEMBL10890976

SCHEMBL10890976

CCCC(=O)NC1=NN(c2nc3c(s2)CCCC3)C(c2ccccc2)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 12/20 0.43
▸ LMNA P02545 9/20 0.43
▸ MAPT P10636 8/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ NPSR1 Q6W5P4 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ SLC12A2 P55011 1/20 0.41
▸ SLC12A5 Q9H2X9 1/20 0.41
▸ SLC27A1 Q6PCB7 1/20 0.41
▸ SMN1; SMN2 Q16637 5/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ HTT P42858 3/20 0.39
▸ TSHR P16473 2/20 0.39
▸ PRNP P04156 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10891764 0.88 MEN1 (0.45) ALDH1A1LMNAMAPTKMT2AMEN1
SCHEMBL10892079 0.83 SLC27A1 (0.35) ALDH1A1LMNAMAPTKMT2AMEN1
SCHEMBL10891545 0.82 ALDH1A1 (0.36) ALDH1A1LMNAMAPTKMT2AMEN1
SCHEMBL10894037 0.82 MAPT (0.35) ALDH1A1LMNAMAPTNPSR1KDM4E
SCHEMBL10887197 0.81 MEN1 (0.37) ALDH1A1LMNAMAPTKMT2AMEN1
SCHEMBL10891246 0.75 GAA (0.40) ALDH1A1LMNAMAPTKMT2AMEN1
SCHEMBL10890556 0.74 MAPT (0.40) ALDH1A1LMNAMAPTKMT2AMEN1
SCHEMBL11057349 0.72 MEN1 (0.54) ALDH1A1LMNAMAPTKMT2AMEN1
SCHEMBL10654320 0.70 ABL1 (0.50) ALDH1A1LMNAMAPTKMT2AMEN1
SCHEMBL10890607 0.69 PARP1 (0.43) ALDH1A1LMNAMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4600722-A 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazolines and a process for the treatment of inflammatory or allergic processes in humans A. NATTERMANN & CIE GMBH (DE) 1986-07-15 — — US disclosed
EP-0155523-A1 3-Amino-1-(4,5,6,7-Tetrahydro-benzothiazolyl)-2-Pyrazolines,a process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-25 — — EP disclosed
Send feedback